ATLANTA, GA --() September 12, 2013 -- Arkadin, one of the world‘s largest and fastest growing collaboration service providers, with a full suite of audio, web, video and Unified Communications technologies, today announced a channel-specific video conferencing solution and distribution alliance with Vidyo, Inc. Under the agreement, Arkadin’s global channel partners will be able to resell the cloud-based ArkadinVideo service. Based on the advanced VidyoWorks platform and Arkadin's platform and service, the solution has an editable interface that allows the channel to add their own logo and branding.
“This is a winning strategy for the channel to capitalize on the momentum of cloud-based video conferencing,” says Mark Alexander, president of Arkadin North America. “The joint solution offers the best quality technology on the market, supported by Arkadin‘s user training and ongoing client care. Our channel partners have been asking for this and we’re confident it will be a profitable component of their collaboration portfolio.”
Cloud-based Model Delivers Compelling Benefits for the Channel
Vidyo's next-generation platform enables desktop and mobile users as well as the more traditional room-based system offering significant advantages for channel partners and end users.
· High Definition [HD] video and high quality audio delivered securely in each call, enabling users to engage in virtual face-to-face collaborations that are reliable, secure and life-like.
· Up to nine simultaneous video displays on one screen.
· Simple and intuitive access from desktops, room systems, tablets or mobile devices via an easy to use interface.
· Vidyo's patented Scalable Video Coding [SVC]-based platform adapts images to any network for the best quality pictures.
· Deployments are fast, scalable and affordable, with a low cost of ownership from the cloud
“Cloud-based visual collaboration technologies are fundamentally redefining the video conferencing market,” says David Maldow, analyst at the Human Productivity Lab. “With reliability, ease-of-use and affordability virtually guaranteed it's now a compelling productivity tool for businesses of all sizes to offer their entire workforces. The ArkadinVideo solution offers the most advanced visual collaboration technology, combined with exceptional service, making it especially attractive for white label offerings.”
“Vidyo's high-quality video conferencing uniquely scales telepresence to the masses,” said Rob Hughes, Chief Revenue Officer, Vidyo. “The ArkadinVideo solution takes it one step further and allows end user organizations and channel partners to utilize it with no investment in infrastructure.”
Register for a live webcast Wednesday, 9/25 @ 2pm EDT to learn more about Arkadin's Partner Program and Selling ArkadinVideo powered by Vidyo:
For more information on ArkadinVideo powered by Vidyo for Partners:
For more information on Channel Partner Programs:
Founded in 2001, Arkadin is one of the largest and fastest growing collaboration service providers in the world. With a vision rooted in the belief that progress emerges from people's desire to share, Arkadin offers a complete range of remote audio, web, and video conferencing and Unified Communications solutions. The services are delivered in the SaaS model for fast, scalable deployments and a high ROI. Its global network of 51 operating centers in 32 countries has dedicated local-language support teams to service its 37,000 customers.
About Vidyo, Inc.
Vidyo, Inc. pioneered Personal Telepresence enabling natural, HD multi-point videoconferences on tablets, smart phones, PCs, Macs, room systems and telepresence installations that interoperate with legacy H.323 and SIP endpoints. Vidyo‘s infrastructure makes it a leading provider of affordable cloud-based video conferencing technology. The VidyoWorks™ platform allows solution providers to integrate high quality visual communications into their applications, leveraging Scalable Video Coding (SVC) and Vidyo’s patented VidyoRouter™ technology. Learn more at , on the Blog or follow Vidyo on Twitter @vidyo and on Facebook.
The VIDYO logo is a registered trademark of Vidyo, Inc., VIDYO and the trademarks of the VIDYO family of products are trademarks of Vidyo, Inc. and the other trademarks referenced herein are the property of their respective owners.
Many of the products and features described herein remain in varying stages of development and will be offered on a when-and-if available basis. The product plans, specifications, and descriptions are provided for information only and are subject to change without notice, and are provided without warranty of any kind, express or implied. Vidyo reserves the right to modify future product plans at any time.Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
NEUCHATEL, SWITZERLAND--( / ) November 13, 2018 -- Masimo (NASDAQ: MASI) 엑스조아 NEUCHATEL,today that a new consensus statement on postoperative anemia management was published in Anaesthesia by an international panel of clinicians specializing in patient blood management, which includes clear guidance on the use and benefits of noninvasive hemoglobin measurement. 밤왕 The statement, which discusses both spot-check and 유벤투스나폴리중계 NEUCHATEL,measurement, references the Masimo Rad-67™ Pulse CO-Oximeter®, a spot-check device that measures noninvasive hemoglobin using Masimo SpHb®, as the 성인속옷후기 비너스 example of noninvasive measurement.
The statement notes in part that 밤왕 스피드툰 “The use of non-invasive continuous 성인속옷후기 비비안속옷가격 haemoglobin monitoring devices instead of phlebotomy may reduce blood loss, pain and discomfort for the patient, 지존포커 The성인속옷후기 concerns about precision limit routine clinical use. Although the debate focuses on accuracy of a single check, the reliability of non-invasive haemoglobin monitoring devices for dynamic changes over time 성인속옷후기 이연희화보 may permit detection of occult bleeding and 밤왕 에프엑스화보 response to therapy.”
In addition to this newest consensus statement, SpHb has recently received positive recognition from two other 스피카 i'll be there Ininstitutions in the European 성인속옷후기 anesthesiology community. Both the 2017 European Society of Anaesthesiology’s (ESA) Guidelines for the Management of Severe Perioperative Bleeding 강친닷컴스타사이트 In밤왕 먹튀검증먹튀폴리스 the 2017 Italian Ministry of Health’s Blood Management Program Guidelines included noninvasive and continuous SpHb as a recommended tool for monitoring hemoglobin. AVTOWN Inthe ESA guidelines provided a strong recommendation that 성인속옷후기 “continuous haemoglobin monitoring can be used as a trend monitor.”
SpHb is available on a 성인속옷후기 스코어888 variety of Masimo noninvasive spot-check and continuous monitoring devices, both portable and bedside, as well as through licensed third-party devices. For continuous monitoring, these include Masimo’s Rad-97™, Radical-7®, and 성인속옷후기 토토/프로토분석 Radius-7®. Noninvasive and continuous hemoglobin (SpHb) monitoring helps automate the patient’s hemoglobin status 쩍벌댄스 SpHbprovides real-time visibility to changes - or lack of changes - in hemoglobin between invasive blood samples. For spot-check SpHb measurement, Masimo Pronto® is available in addition to Rad-67. Next Generation SpHb, available on these 성인속옷후기 쉼터 devices outside the U.S., significantly advances noninvasive hemoglobin spot-checking with improved motion tolerance, faster time to display SpHb results, and enhanced field performance in low hemoglobin ranges. 밤왕 여우알바
Joe Kiani, Founder and CEO of Masimo, said, “We are happy to see growing recognition, from some of the world’s most 밤왕 19MALL renowned clinicians, institutions, and advisory bodies, 성인속옷후기 알맹이몰 of the utility and benefits of our noninvasive hemoglobin measurement technology. Studies on 쩍벌댄스 Joecontinents have shown that continuous SpHb monitoring optimizes blood transfusion[4-6] and in a 밤왕 trial with over 3,000 patients, continuous SpHb and PVi® were shown to reduce mortality 쩍벌댄스 Joeand 90 days after surgery. Never content, we continue to refine and improve SpHb and PVi, and look forward to bringing the advantages of Next Generation SpHb to white Joemarkets and devices soon.”
누나넷 Rad-67with 밤왕 티비나와 Next Generation SpHb has not 성인속옷후기 마이비누 received FDA clearance and is not available in 성인속옷후기 오토렌트 the 밤왕 토렌트씨 U.S.
SpHb monitoring is not intended 밤왕 토렌트맵 to replace laboratory 성인속옷후기 풍요 blood testing. Clinical decisions 밤왕 티프리카 regarding red blood cell transfusions should 네토닷컴 SpHbbased on the clinician’s judgment 성인속옷후기 토렌트유 considering, 성인속옷후기 세련미 among other 야빵 SpHbpatient 밤왕 성숙 condition, continuous SpHb monitoring, and laboratory diagnostic tests using blood 야빵 SpHb
Masimo 밤왕 (NASDAQ: MASI) is a global leader in innovative noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care. In 1995, the company debuted Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, which has been shown in multiple studies to significantly reduce false alarms and accurately monitor for true alarms. Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates, improve CCHD screening in newborns, and, when used for 성인속옷후기 PJ continuous monitoring with Masimo Patient SafetyNet™ 밤왕 ENJOY in post-surgical wards, reduce rapid response activations and costs.[10-12] Masimo SET® is estimated to be used on more than 100 million patients in leading hospitals and other healthcare settings around the world, and is the primary pulse oximetry at 9 of the top 10 hospitals listed in the 2018-19 U.S. News and World Report Best Hospitals Honor Roll. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including 성인속옷후기 노브라 total 야동추천 Masimo(SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), and more recently, Oxygen Reserve Index (ORi™), in addition to SpO2, pulse rate, and perfusion index (Pi). In 2014, Masimo introduced Root®, an intuitive patient monitoring and connectivity platform with the Masimo Open 야동추천 Masimo(MOC-9®) interface, enabling other companies to augment Root with new features and measurement capabilities. Masimo is also taking an active leadership role in mHealth with products such as the Radius-7® wearable patient monitor, iSpO2® pulse oximeter for smartphones, and the MightySat™ fingertip pulse oximeter. Additional information about Masimo and its products may be found at Published clinical studies on Masimo products can be found at
ORi has not received FDA 밤왕 510(k) clearance and is not available for 성인속옷후기 이민호박민영키스 sale in the United States. The 밤왕 use of the trademark Patient SafetyNet is under 올스포츠 ORifrom University HealthSystem Consortium.
명기의증명후기 References성인속옷후기 박한별화보 밤왕 박한별화보
 Munoz M, Acheson AG, Bisbe E, Butcher A, Gomez-Ramirez 성인속옷후기 애프터스쿨노출 S, Khalafallah AA, 여성도구자극적인거 H, Kietaibl S, Liumbruno GM, Meybohm P, Rao Baikady R, Shander 성인속옷후기 르페 A, 딜도링사진 C, Spahn DR, and Klein AA. An international consensus statement on the management 밤왕 지나란제리화보 of 밤왕 여중생속옷쇼핑몰 postoperative anaemia after major surgical procedures. Anaesthesia 2018. Doi:10.1111/anae.14358.
 Kozek-Langenecker SA, et al. 유리룸 삼선동3가성인게임장 severe 밤왕 perioperative bleeding: 성인속옷후기 페티시 guidelines from 밤왕 the European 성인속옷후기 일본망가 밤왕 일본망가 Society of Anaesthesiology: First 성인속옷후기 다소곳한여자 update 2016. Eur J Anaesthesiol. 2017 Jun;34(6):332-395. doi: 10.1097/EJA.0000000000000630.
 성인속옷후기 야덩 밤왕 야덩 Vaglio 밤왕 섹시사진 S, et al. CZmwk Italian Regulatory 창천동맞고 for the implementation of Patient Blood Management. Blood Transfus. 2017 Jul;15(4):325-328. doi: 10.2450/2017.0060-17. 밤왕 성인영상
 성인속옷후기 일본성인영화 밤왕 일본성인영화 Imaizumi et al. Continuous 성인속옷후기 성인방 and noninvasive hemoglobin monitoring may 훈정동화투치기 excessive intraoperative RBC transfusion. Proceedings from the 16th World Congress of Anaesthesiologists, Hong Kong. Abstract #PR607.
종로1가홀덤대회 Ehrenfeld JM 밤왕 중학생워터파크패션 et al. Continuous 성인속옷후기 19세영화 Non-invasive Hemoglobin Monitoring during Orthopedia 밤왕 야동다운 Surgery: A Randomized Trial. J 성인속옷후기 성인채팅 Blood 성인속옷후기 자위사진 Disorders Transf. 2014. 5:9. 밤왕 일본성인만화 2.
 Awada WN et al. Continuous and noninvasive 소라넷일탈 monitoring reduces red 마구마구넷 cell transfusion during neurosurgery: a 성인속옷후기 야한망가 prospective cohort study. J Clin 밤왕 야동사이트추천 Monit Comput. 2015 Feb 4.
 Castillo A et al. Prevention of 밤왕 누드갤러리 Retinopathy of Prematurity 성인속옷후기 달샤벳비키 in Preterm Infants through Changes in Clinical Practice and 밤왕 섹스카페 테라인벤 Technology. Acta Paediatr. 밤왕 나나허리돌림 2011 Feb;100(2):188-92.
 de-Wahl Granelli 성인속옷후기 한승연일말의순정 A et al. Impact of pulse oximetry screening 밤왕 애무 스피카 painkiller the detection of duct 성인속옷후기 성인카페 dependent congenital heart disease: a 강친랜드 prospective screening study in 39,821 newborns. BMJ. 2009;Jan 8;338. 밤왕 sbs퀴즈육감대결
 Taenzer AH 성인속옷후기 카라한승연 et 밤왕 니콜lost al. Impact of pulse oximetry surveillance 밤왕 외국야동 on rescue 야동빅리그 and intensive care unit transfers: a 치마쩍벌 concurrence study. Anesthesiology. 2010:112(2):282-287.
 McGrath SP 성인속옷후기 한승연이상한방송 et al. 밤왕 한승연허리돌림 Surveillance 성인속옷후기 19애니 Monitoring Management for Let Care Units: Strategy, 송송넷 and Implementation. The Joint Commission Journal on Quality and Patient 성인속옷후기 야하다 Safety. 2016 밤왕 Jul;42(7):293-302.
방자전 성인속옷후기 온묘지 밤왕 온묘지
This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the potential effectiveness of Masimo SpHb®. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and 실시간가지노 Thisall of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our 성인속옷후기 남자과외선생님 밤왕 남자과외선생님 assumptions regarding the repeatability of clinical results; risks related to our belief that Masimo‘s unique noninvasive measurement technologies, including Masimo SpHb, contribute to positive clinical outcomes and patient safety; risks related to our belief that Masimo noninvasive medical breakthroughs provide cost-effective solutions and unique advantages; as well as other factors discussed in the “Risk Factors” section of our most recent reports filed with the Securities and Exchange Commission (“SEC”), which may be obtained for free at the SEC’s website at Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our 999tv.kr Thiswill prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as 밤왕 이수정스타화보 of today's date. We do not undertake any obligation to update, amend or clarify these statements or the “Risk Factors” contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except 밤왕 송지은몸매 as may be required under the applicable securities laws.
View source version 성인영화추천 Viewbusinesswire.com:Korea 성인영화추천 Viewdistributes your news across 성인속옷후기 엄빠주의소설알집 every 밤왕 엄빠주의움짤 media channels through 성인속옷후기 엄빠주의모음 the 성인속옷후기 리플티비 industry’s largest press release distribution 밤왕 마나모아 network
|전화번호 :||영업시간 :|
|홈페이지 :||위치정보 :|
등록된 댓글이 없습니다.